Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
You need to sign in or sign up before continuing.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Merck & Co. Inc. buy Royal Bank of Canada

Start price
€111.06
08.07.26 / 50%
Target price
€124.38
08.07.27
Performance (%)
15.04%
Price
€127.76
22:25
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 15.04%. This prediction currently runs until 08.07.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Merck & Co. Inc. 13.001% 13.001%
iShares Core DAX® -1,06 % 5,01 %
iShares Nasdaq 100 -2,39 % 0,86 %
iShares Nikkei 225® -4,36 % 1,21 %
iShares S&P 500 -1,78 % 1,39 %

Comments by Royal_Bank_of_Canada for this prediction

In the thread Merck & Co. Inc. diskutieren
Prediction Buy
Perf. (%) 15.04%
Target price 124.378
Change
Ends at 08.07.27

Merck & Co., Inc. (MRK) had its "outperform" rating reaffirmed by Royal Bank Of Canada. They now have a $142.00 price target on the stock.
Ratings data for MRK provided by MarketBeat

Stopped prediction by Royal_Bank_of_Canada for Merck & Co. Inc.

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€102.80
30.03.26
€123.30
30.03.27
24.28%
22:25

buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€105.40
25.02.26
€120.47
25.02.27
21.21%
22:25